New discovery may lead the way to improved whooping cough vaccine
Scientists at Trinity College Dublin have made novel discoveries concerning the current vaccine against whooping cough that may lead to the development of an improved future vaccine. The findings could help reduce the incidence ...
Diseases, Conditions, Syndromes
May 13, 2013 |
not rated yet |
0
ER visits tied to ambien on the rise
(HealthDay)—There has been a dramatic increase in the number of emergency-room visits related to sleep medications such as Ambien, according to a new U.S. study.
Medications
May 01, 2013 |
not rated yet |
0
Drugs without side effects: Researchers explore novel ways to classify proteins
Janelle Leuthaeuser is on the cutting edge of biophysics. A molecular genetics and genomics Ph.D. student, she is part of a nationwide effort to create a more efficient generation of protein-based drugs.
Medical research
Apr 26, 2013 |
5 / 5 (1) |
0
|
Severe cutaneous adverse rxns up in allopurinol initiators
(HealthDay)—Allopurinol initiators have an almost 10-fold increased risk of severe cutaneous adverse reactions (SCARs) compared with nonusers, according to a study published in the April issue of Arthritis Ca ...
Arthritis & Rheumatism
Apr 23, 2013 |
not rated yet |
0
Genes reveal which patients will benefit from scleroderma drug
Systemic sclerosis, also known as scleroderma, is a rare autoimmune connective tissue disorder that's difficult to treat. However, thanks to new research at Northwestern University Feinberg School of Medicine and Dartmouth's ...
Diseases, Conditions, Syndromes
Apr 10, 2013 |
not rated yet |
0
Study examines the role adverse reactions play in statin discontinuation
Despite their well-documented benefits, statins, drugs used to lower cholesterol, are commonly discontinued in routine care. Statin discontinuation has been linked to increased risk for cardiovascular events and death in ...
Cardiology
Apr 01, 2013 |
not rated yet |
0
Lymphoseek approved to help locate lymph nodes
(HealthDay)—The injected imaging drug Lymphoseek (technetium Tc 99m tilmanocept) has been approved by the U.S. Food and Drug Administration to help surgeons locate the lymph nodes among people with breast cancer or melanoma.
Cancer
Mar 13, 2013 |
not rated yet |
0
New report offers assurance, future research on kids' shots
New parents quickly learn that their kids have years of vaccinations ahead of them. The vast majority of parents keep up with the schedule but some parents diverge from the recommended timeline, and a small minority object ...
Health
Jan 18, 2013 |
not rated yet |
0
Octaplas approved for blood-clotting disorders
(HealthDay)—Octaplas has been approved by the U.S. Food and Drug Administration to augment insufficient clotting proteins that could otherwise lead to excessive bleeding or excessive clotting.
Medications
Jan 17, 2013 |
not rated yet |
0
Changing advice: Egg-allergic patients should get flu vaccine without delay
New recommendations from a task force of allergy experts advise people with an egg allergy to get a flu vaccine, and not to delay with allergy testing before the vaccine. Patients had previously been caution ...
Immunology
Jan 15, 2013 |
not rated yet |
0
Signifor approved for Cushing's disease
(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.
Medications
Dec 17, 2012 |
not rated yet |
0
Recent increase in adverse TMP-SMX reactions in children
(HealthDay)—There has been a significant increase in adverse drug reactions (ADRs) associated with use of trimethoprim-sulfamethoxazole (TMP-SMX) for treatment of skin and soft tissue infection (SSTI) in ...
Pediatrics
Dec 03, 2012 |
not rated yet |
0
Medications are being discontinued—and the pharmacist may not know
More than 85,000 medications are discontinued each year by physicians, yet while physicians share this information with their patients, it is too often not shared with the pharmacists. This communication gap, identified by ...
Medications
Nov 19, 2012 |
not rated yet |
0
Xeljanz approved for rheumatoid arthritis
(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.
Arthritis & Rheumatism
Nov 07, 2012 |
not rated yet |
0
BMJ editor urges Roche to fulfil promise to release Tamiflu trial data
In an open letter to company director, Professor Sir John Bell, she says: "Billions of pounds of public money have been spent on [Tamiflu] and yet the evidence on its effectiveness and safety remains hidden from appropriate ...
Medications
Oct 30, 2012 |
not rated yet |
0
